Page last updated: 2024-08-24

1,2-distearoyllecithin and Sarcoma 180

1,2-distearoyllecithin has been researched along with Sarcoma 180 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishigori, H; Ogihara-Umeda, I; Sasaki, T1
Kojima, S; Ogihara-Umeda, I1

Other Studies

2 other study(ies) available for 1,2-distearoyllecithin and Sarcoma 180

ArticleYear
Development of a liposome-encapsulated radionuclide with preferential tumor accumulation--the choice of radionuclide and chelating ligand.
    International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1992, Volume: 19, Issue:7

    Topics: Animals; Chelating Agents; Cholesterol; Chromium Radioisotopes; Cobalt Radioisotopes; Drug Carriers; Gallium Radioisotopes; Iron Radioisotopes; Ligands; Liposomes; Male; Mice; Mice, Inbred Strains; Phosphatidylcholines; Sarcoma 180; Time Factors; Tissue Distribution

1992
Cholesterol enhances the delivery of liposome-encapsulated gallium-67 to tumors.
    European journal of nuclear medicine, 1989, Volume: 15, Issue:9

    Topics: Animals; Cholesterol; Drug Carriers; Gallium Radioisotopes; Liposomes; Male; Mice; Neoplasm Transplantation; Phosphatidylcholines; Sarcoma 180; Tissue Distribution

1989